First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study

First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study

IntroductionThe incidence of preeclampsia (PE) is about 2–8%, making it one of the leading causes of perinatal morbidity and maternal mortality in the world. Early prophylactic low dose administration (150 mg) of acetylsalicylic acid is associated with a significant reduction in the incidence of ear...

Full description

Bibliographic Details
Main Authors: Cristina Trilla, Cristina Luna, Silvia De León Socorro, Leire Rodriguez, Aina Ruiz-Romero, Josefina Mora Brugués, Taysa Benítez Delgado, Marta Fabre, Alicia Martin Martínez, Sara Ruiz-Martinez, Elisa Llurba, Daniel Oros
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
screening
first trimester
sequential
preeclampsia
growth restriction
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.931943/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.931943/full

Similar Items